Developing Expertise in Cognitive Behavior Therapy for Insomnia (CBT-I)

Gregg Jacobs, Ph.D.

10/18/2019 at 9:00 am - 4:45 pm

Reno, location tba
Reno
Reno, NV

6 CE Credits

 

APA Approved Sponsor logo_white background_screen imageApproved for Nevada Psychologists and MFTs. Approval pending: LCSWs. NPA is approved by the American Psychological Association to sponsor continuing education for psychologists. NPA maintains responsibility for this program and its content.

 

    About the Workshop:

    Chronic insomnia is highly prevalent as a primary or co-morbid disorder. CBT-I is now considered the first-line treatment for chronic insomnia due to its superior long-term efficacy, lack of side effects, and patient preference. It is also the most efficacious psychological therapy for a health problem. It improves sleep in 70-80% of patients, is more effective than sleeping pills, and reduces or eliminates sleeping pills in the vast majority of patients, and doubles the improvement rates of depression compared to antidepressant medication alone in depressed patients with insomnia. It also improves other co-morbidities including pain and fibromyalgia, substance abuse, PTSD, and menopausal hot flashes. As a result, chronic insomnia is now considered an independent disorder that should be treated separately from co-morbid conditions.

    Compared to CBT-I, sedative-hypnotics are associated with significant side effects and dangers including elevated mortality risk that has resulted in new FDA black box warnings about the potentially fatal side effects of Ambien, Lunesta, and Sonata. As a result of the black box warning, more patients and their physicians will be choosing CBT-I as a safe and more effective treatment option. However, there is a dire shortage of clinicians and sleep clinics with expertise in CBT-I due to the scarcity of training opportunities in this area.

    This workshop will enable clinicians to develop competence in CBT-I using an empirically and clinically validated CBT-I protocol. It is based on almost three decades of clinical practice and research at Harvard Medical School and the University of Massachusetts Memorial Medical Center  involving over 10,000 insomnia patients and a landmark federally-funded study conducted at Harvard Medical School by Gregg D. Jacobs, Ph.D. and colleagues  demonstrating that the same CBT-I protocol  was more effective than Ambien ((Jacobs, GD, et al. Cognitive Behavior Therapy and Pharmacotherapy for Insomnia: a Randomized Controlled Trial and Direct Comparison. Archives of Internal Medicine, 2004, 164: 1888-96).

    The workshop includes a brief CBT-I training manual for clinicians. A more detailed, 200 page CBT-I clinician training manual will be available for a reduced price of $75.00 (normally $195 for solo practitioners). The manual includes step-by-step treatment manuals for use with individuals and groups and all program materials (relaxation techniques compact disk, sleep diaries, progress summaries, and brochures) for implementing CBT-I in clinical practice.

    Learning Objectives:

    At the end of this program, participants will be able to:
    1. Describe the empirical support of CBT-I.
    2. Recognize basic sleep and insomnia physiology and how the elderly show changes in their sleep patterns.
    3. List the efficacy, side effects, and risks of sleep medications used to treat insomnia and why these are greater for women and the elderly.
    4. Conduct a sleep-focused assessment of insomnia patients.
    5. Describe the rationale for, and be able to implement, CBT-I techniques including cognitive restructuring, sleep scheduling, stimulus control, relaxation, sleep hygiene, and sleep medication tapering and a sleep diary.
    6. Discuss sample case studies.

    Audience:

    This presentation is intended for psychologists, other licensed mental health providers, and graduate students of psychology. Seating is limited, so register early!

    About the Speaker:

    Gregg D. Jacobs, Ph.D., is a sleep psychologist and has spent thirty years researching and treating insomnia at the Harvard and University of Massachusetts Medical Schools. His insomnia research was funded by the National Institutes of Health and published in journals such as the Archives of Internal Medicine. He has taught his insomnia program to over 10,000 patients, to HMOs such as Kaiser Permanente and Fortune 500 companies such as Reebok, Fidelity, and John Hancock, and his insomnia program has been used by major insurers such as Blue Cross and Blue Shield and Fortune 500 companies such as Raytheon. Dr. Jacobs is the author of Say Good Night to Insomnia (New York: Henry Holt), which has been translated into eight languages, and he has been described by the Wall Street Journal as a “pioneer in the use of cognitive-behavioral therapy for insomnia”. Dr. Jacobs’ CV

Download Brochure:

Click here to download brochure
Fax to:
(888) 654-0050 (for credit cards)
Mail with check to:
PO Box 400671, Las Vegas, NV 89140

Sign Up for this Event

Online bookings are not available for this event.